A profile and review of findings from the Early Markers for Autism study: unique contributions from a population-based case-control study in California.

This is a narrative review of many analyses from one case-control study, not a single pre-specified test, so there is no one primary result to judge. The study can show associations between archived prenatal or newborn markers and later diagnosis, but it cannot prove that any marker caused autism. Many findings were inconsistent or null, especially for vitamin D, air pollution, and combined chemical exposures. The paper summarizes earlier publications rather than presenting one new analysis, so the strength of each finding depends on the separate study behind it. Children with milder autism were less likely to be captured in the records, so findings may apply more to children who received services. There were few female autism cases. This limits sex-specific conclusions. No clinical outcomes, therapy response, or communication measures were assessed, so the paper cannot guide treatment. Some subgroup findings, such as effects by sex or ethnicity, may be chance and need replication. Prenatal confounder information was limited. Parental psychiatric history and maternal diet were not available. Environmental exposure findings may not apply elsewhere because vitamin D deficiency was low and air pollution exposure was relatively high in Southern California.

The supplied funding statement names the National Institutes of Health and the Tobacco-Related Disease Research Program. It does not give author conflict-of-interest declarations.

Do not conclude that immune markers, vitamin D, or chemical exposures cause autism or that changing them will prevent autism. These are observational associations from archived prenatal and newborn samples, many results showed no clear association or were inconsistent, and the paper reports no treatment or prevention outcomes.